FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical composition in form of solid dosage form for treatment or prevention of diabetes, which contains therapeutically efficient quantity of metformin, polyvinylpyrrolodone, stearic acid and/or its salt, starch, silicon dioxide, characterised by the fact that as polyvinylpyrrolidone it contains polyvinylpirrolidone with molecular weight from 1000000 to 1500000 and additionally glycerol and/or basic finely dispersed magnesium carbonate.
EFFECT: pharmaceutical composition possesses high strength and ensures high degree of active substance release.
10 cl, 1 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL ANTI-DIABETIC COMPOSITION OF PROLONGED ACTION | 2011 |
|
RU2465896C2 |
| COMPLEX MEDICAL FORM WITH CONTROLLED RELEASE FOR PERORAL INTRODUCTION OF MEDICATION AGAINST DIABETES AND METHOD OF OBTAINIG IT | 2005 |
|
RU2355386C2 |
| PHARMACEUTICAL COMPOSITION OF ANTIHYPERTENSIVE AND DIURETIC ACTION, AND METHOD FOR ITS OBTAINING | 2002 |
|
RU2201751C1 |
| COMPOSITION OF HYPOLIPIDEMIC AND HEPATOPROTECTIVE ACTIVITY | 2007 |
|
RU2329051C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DIABETES MELLITUS (VARIANTS) | 2003 |
|
RU2241449C1 |
| DRY GRANULATION PROCESS FOR PRODUCING TABLET COMPOSITIONS OF METFORMIN AND COMPOSITIONS THEREOF | 2013 |
|
RU2647421C2 |
| DOSAGE FORM IN CAPSULE FORM CONTAINING TABLETS WITH DIMETHYL FUMARATE | 2019 |
|
RU2742745C1 |
| PHARMACEUTICAL COMPOSITION ELICITING ANTICONVULSANT AND PSYCHOTROPIC EFFECT AND METHOD FOR ITS PREPARING | 2003 |
|
RU2240798C1 |
| TWO-LAYER TABLET COMPOSITION | 2020 |
|
RU2824129C2 |
| DOUBLE-LAYER TABLET COMPOSITION | 2010 |
|
RU2712757C2 |
